Upgrade to SI Premium - Free Trial

PTC Therapeutics (PTCT) PT Raised to $130 at Cantor Fitzgerald on PKU Launch

July 16, 2026 7:23 AM
Cantor Fitzgerald analyst Kristen Kluska raised the price target on PTC Therapeutics (NASDAQ: PTCT) to $130.00 (from $124.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change